Keros Capital Update: Emerging Growth Research, LLP Issues a Speculative Buy Rating and $4 Target Price for Kraig Biocraft Labs

    LANSING, MI, Aug. 5 /CNW/ - Kraig Biocraft Laboratories, Inc. (OTCBB:
KBLB), Emerging Growth Research, LLP issued a report late last month on Kraig
Biocraft Labs putting a Speculative BUY rating and a target price of $4 a
share. Analyst Joseph Noel said "We are clearly excited about this company's
prospects to develop a 'super fiber' that can be sold into the technical
textiles industry".
    The report states the company is in possession of the coded gene
sequences relating to spider silk production and is currently working on
microinjections of this material into silkworm eggs. No requirement for FDA
approval enables the company to fast track into production, licensing
agreements or direct sale once microinjection is successful, which is
estimated by the end of 2008.
    The report is available for free download at:

    Kraig Biocraft Labs Kraig Biocraft Laboratories is a technology company
focused on the development of commercially significant high-performance
polymers, technical fibers and diverse platform technologies. Based on
proprietary genetic engineering technology, Kraig is working to develop and
produce polymers and protein-based materials including Spider Silk.
    To receive immediate notification of all companies Keros Capital covers,
enter your email at
    Kraig Biocraft Labs trades on the OTC Bulletin Board exchange under the
symbol KBLB, other Bulletin Board and Pink Sheet to watch are: Nutracea
(OTCBB: NTRZ) up 51% on 5.7 million shares, Neomedia Technologies Inc (OTCBB:
NEOM) up 75% on 43.7 million shares, Quest Minerals and Mining LTD (OTCBB:
QMNM) up 18% on 43 million shares,
    Nasdaq stocks to watch include Sirius Satellite Radio Inc (Nasdaq:   SIRI)
down 4.8% on 180 million shares, PeopleSupport Inc (Nasdaq:   PSPT) up 25% on
6.4 million shares, Amgen Inc (Nasdaq:   AMGN) up 1.4% on 10 million shares,
Biogen Idec Inc. (Nasdaq:   BIIB) down less than 1% on 8.9 million shares,
Gilead Sciences Inc (Nasdaq:   GILD) up less than 1% on 6.2 million shares,
Vertex Pharmaceuticals Inc (Nasdaq:   VRTX) down 8.4% on 10 million shares,
Celgene Corp (Nasdaq:   CELG) down 1% on 3.7 million shares, Sepacor Inc
(Nasdaq:   SEPR) up 1% on 2.6 million shares.
    NYSE stocks to watch: Genentech Inc (NYSE:   DNA) up less than 1% on
2.4 million shares.

    Disclosure: All material herein was prepared by Keros Capital Inc.
(Keros) based upon information believed to be reliable. The information
contained herein is not guaranteed by Keros to be accurate, and should not be
considered to be all-inclusive. The companies that are discussed in this
opinion have not approved the statements made in this opinion. This opinion
contains forward-looking statements that involve risks and uncertainties. This
material is for informational purposes only and should not be construed as an
offer or solicitation of an offer to buy or sell securities. Keros is not a
licensed broker, broker dealer, market maker, investment banker, investment
advisor, analyst or underwriter. Please consult a broker before purchasing or
selling any securities viewed on or mentioned
herein. Keros has been compensated two thousand five hundred dollars for KBLB.
Keros affiliates, officers, directors and employees may own shares and may buy
and sell additional shares of the company mentioned herein and may profit in
the event those shares rise in value. Keros will not advise as to when it
decides to sell and does not and will not offer any opinion as to when others
should sell; each investor must make that decision based on his or her
judgment of the market.

For further information:

For further information: Jim Mav, (973) 979-3705

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890